Acticor Biotech ^{R&D and Labs}

Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke.

Headquarters: Paris, Ile-de-France, France

Founded Date: 2010-01-01

Funding Status: Early Stage Venture

Total Funding: $33 202 489

Estimated Revenue: $1M to $10M

Last Funding Date: 2019-11-06

Last Funding Type: Series B

Acticor Biotech R&D and Labs